Conclusion
Our findings add to the growing evidence that SES and health care
coverage are strong prognostic factors that influence the stage of
presentation for children and AYA with sarcoma, potentially reflecting
decreased access to care for these patients and families. Further
studies are needed in order to evaluate mechanisms that underlie these
disparities so that interventions may be designed to improve outcomes in
this population.